{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T20:25:26Z","timestamp":1767990326180,"version":"3.49.0"},"reference-count":54,"publisher":"Bentham Science Publishers Ltd.","issue":"15","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPB"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>In the last few years, the possible etiological role of the Hepatitis B virus\n(HBV) in the outbreak of extrahepatic pathologies has been studied, including lymphomas. The\nWorld Health Organization (WHO) estimates that around 257 million people live with chronic\nHBV infection, and to date, the vaccine is the most effective means of prevention.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>The aim of this review was to evaluate whether the vaccination against Hepatitis B can\nlead to a reduction in lymphoma cases and has a protective role.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>A literature search was conducted in April 2020 using the databases Scopus, PubMed,\nand ISI Web of Science. Search terms included: \u201cHepatitis B vaccination AND lymphoma.\u201d All\narticles evaluating the association between Hepatitis B vaccination and the prevention of lymphoma\nwere selected. No limits were applied.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>Eight studies were eligible to be included in the review. Data showed that association\nbetween lymphoma and HBV infection is not the same for all types of lymphomas, but it appears\nto be more significant for Non-Hodgkin Lymphoma (NHL). The results from all the considered\narticles were not unitary. This is because studies were conducted in different countries with different\nendemicity of Hepatitis B, different vaccination coverage, treatment of chronic Hepatitis, and\nprevention of its complications, as well as the availability of data for researchers. No statistically\nsignificant association was found between HBV vaccination and the development of lymphomas.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Although the literature is still largely lacking regarding the protective effect of anti-\nHBV vaccination on lymphoma subtypes, the association between HBV infection and lymphoma\nhas been confirmed in several studies. Vaccination programs eliminate the risk of HBV infection\nand prevent liver disease but can also indirectly reduce the risk of lymphomas.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1389201023666220113111946","type":"journal-article","created":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T13:13:12Z","timestamp":1642684392000},"page":"1864-1872","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The Possible Protective Effect of Hepatitis B Vaccine against Lymphomas: A Systematic Review"],"prefix":"10.2174","volume":"23","author":[{"given":"Giuseppe","family":"La Torre","sequence":"first","affiliation":[{"name":"Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenza","family":"Lia","sequence":"additional","affiliation":[{"name":"Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Grima","sequence":"additional","affiliation":[{"name":"Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Amici","sequence":"additional","affiliation":[{"name":"Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Manzi","sequence":"additional","affiliation":[{"name":"Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Monaci","sequence":"additional","affiliation":[{"name":"Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","unstructured":"Epicentro. L\u2019epidemiologia per la Sanit\u00e0 Pubblcia by The Italian National Institute of Health. Viral Hepatitis, Hepatitis B. Available from:  (accessed on 20 April 2020)."},{"key":"ref=2","unstructured":"Viral Hepatitis, Hepatitis B. Centers for Disease Control and Prevention (CDC)Available from:  (accessed on 20 April 2020)."},{"key":"ref=3","year":"2019","unstructured":"Hepatitis B. World Health Organization (WHO)Available from:  (accessed on 20 April 2020).2019"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"409","DOI":"10.4254\/wjh.v10.i5.409","volume":"10","author":"Stasi C.","year":"2018","unstructured":"Stasi C.; Silvestri C.; Berni R.; Brunetto M.R.; Zignego A.L.; Orsini C.; Milani S.; Ricciardi L.; De Luca A.; Blanc P.; Nencioni C.; Aquilini D.; Bartoloni A.; Bresci G.; Marchi S.; Filipponi F.; Colombatto P.; Forte P.; Galli A.; Luchi S.; Chigiotti S.; Nerli A.; Corti G.; Sacco R.; Carrai P.; Ricchiuti A.; Giusti M.; Almi P.; Cozzi A.; Carloppi S.; Laffi G.; Voller F.; Cipriani F.; Clinical epidemiology of chronic viral hepatitis B: A Tuscany real-word large-scale cohort study. World J Hepatol 2018,10(5),409-416","journal-title":"World J Hepatol"},{"key":"ref=5","first-page":"2212","volume":"30","author":"Ott J.J.","year":"2012","unstructured":"Ott J.J.; Stevens G.A.; Groeger J.; Wiersma S.T.; Global epidemiology of Hepatitis B virus infection: New estimates of agespecific HBsAg seroprevalence and endemicity. Elsevier 2012,30,2212-2219","journal-title":"Elsevier"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/j.1600-0609.2007.00878.x","volume":"79","author":"Lim S.T.","year":"2007","unstructured":"Lim S.T.; Fei G.; Quek R.; Lim L.C.; Lee L.H.; Yap S.P.; Loong S.; Tao M.; The relationship of hepatitis B virus infection and non-Hodgkin\u2019s lymphoma and its impact on clinical characteristics and prognosis. Eur J Haematol 2007,79(2),132-137","journal-title":"Eur J Haematol"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/S1470-2045(10)70167-4","volume":"11","author":"Engels E.A.","year":"2010","unstructured":"Engels E.A.; Cho E.R.; Jee S.H.; Hepatitis B virus infection and risk of non-Hodgkin lymphoma in South Korea: A cohort study. Lancet Oncol 2010,11(9),827-834","journal-title":"Lancet Oncol"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1111\/j.1349-7006.2002.tb01280.x","volume":"93","author":"Kim J.H.","year":"2002","unstructured":"Kim J.H.; Bang Y.J.; Park B.J.; Yoo T.; Kim C.W.; Kim T.Y.; Heo D.S.; Lee H.S.; Kim N.K.; Hepatitis B virus infection and B-cell non-Hodgkin\u2019s lymphoma in a hepatitis B endemic area: A case-control study. Jpn J Cancer Res 2002,93(5),471-477","journal-title":"Jpn J Cancer Res"},{"key":"ref=9","first-page":"200","volume":"23","author":"Mehdi S.R.","year":"2006","unstructured":"Mehdi S.R.; Al Ajlan A.R.; Hepatitis, B. Hepatitis B","journal-title":"Turk J Haematol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1186\/s12885-019-5718-x","volume":"19","author":"Zhou X.","year":"2019","unstructured":"Zhou X.; Pan H.; Yang P.; Ye P.; Cao H.; Zhou H.; Both chronic HBV infection and naturally acquired HBV immunity confer increased risks of B-cell non-Hodgkin lymphoma. BMC Cancer 2019,19(1),477","journal-title":"BMC Cancer"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/j.leukres.2013.06.007","volume":"37","author":"Dalia S.","year":"2013","unstructured":"Dalia S.; Chavez J.; Castillo J.J.; Sokol L.; Hepatitis B infection increases the risk of non-Hodgkin lymphoma: A meta-analysis of observational studies. Leuk Res 2013,37(9),1107-1115","journal-title":"Leuk Res"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"6524","DOI":"10.1038\/sj.onc.1207843","volume":"23","author":"Fisher S.G.","year":"2004","unstructured":"Fisher S.G.; Fisher R.I.; The epidemiology of non-Hodgkin\u2019s lymphoma. Oncogene 2004,23(38),6524-6534","journal-title":"Oncogene"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1177\/107327481502200315","volume":"22","author":"Dalia S.","year":"2015","unstructured":"Dalia S.; Suleiman Y.; Croy D.W.; Sokol L.; Association of lymphomagenesis and the reactivation of hepatitis B virus in non-hodgkin lymphoma. Cancer Contr 2015,22(3),360-365","journal-title":"Cancer Contr"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1053\/j.seminhematol.2018.05.007","volume":"56","author":"Jaffe E.S.","year":"2019","unstructured":"Jaffe E.S.; Diagnosis and classification of lymphoma: Impact of technical advances. Semin Hematol 2019,56(1),30-36","journal-title":"Semin Hematol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1158\/1055-9965.EPI-06-0308","volume":"15","author":"Dal Maso L.","year":"2006","unstructured":"Dal Maso L.; Franceschi S.; Hepatitis C virus and risk of lymphoma and other lymphoid neoplasms: A meta-analysis of epidemiologic studies. Cancer Epidemiol Biomarkers Prev 2006,15(11),2078-2085","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"107","DOI":"10.4254\/wjh.v8.i2.107","volume":"8","author":"Pozzato G.","year":"2016","unstructured":"Pozzato G.; Mazzaro C.; Dal Maso L.; Mauro E.; Zorat F.; Moratelli G.; Bulian P.; Serraino D.; Gattei V.; Hepatitis C virus and non-Hodgkin\u2019s lymphomas: Meta-analysis of epidemiology data and therapy options. World J Hepatol 2016,8(2),107-116","journal-title":"World J Hepatol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s10552-019-01155-5","volume":"30","author":"Miranda-Filho A.","year":"2019","unstructured":"Miranda-Filho A.; Pi\u00f1eros M.; Znaor A.; Marcos-Gragera R.; Steliarova-Foucher E.; Bray F.; Global patterns and trends in the incidence of non-Hodgkin lymphoma. Cancer Causes Control 2019,30(5),489-499","journal-title":"Cancer Causes Control"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"Moher D.","year":"2009","unstructured":"Moher D.; Liberati A.; Tetzlaff J.; Altman D.G.; Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med 2009,6(7),e1000097","journal-title":"PLoS Med"},{"key":"ref=19","author":"Wells G.A.","year":"2011","unstructured":"Wells G.A.; Shea B.; O\u2019Connel D.; Peterson J.; Welch V.; Losos M.; Tugwell P.; The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2011"},{"key":"ref=20","first-page":"31","volume":"2","author":"La Torre G.","year":"2015","unstructured":"La Torre G.; Backhaus I.; Mannocci A.; Rating for narrative reviews: Concept and development of the International Narrative Systematic Assessment tool. Senses Sci 2015,2,31-35","journal-title":"Senses Sci"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-642-38965-8_1","volume":"193","author":"Schiller J.T.","year":"2014","unstructured":"Schiller J.T.; Lowy D.R.; Virus infection and human cancer: An overview. Recent Results Cancer Res 2014,193,1-10","journal-title":"Recent Results Cancer Res"},{"key":"ref=22","first-page":"11","volume":"1","author":"Chen C.J.","year":"2014","unstructured":"Chen C.J.; Hsu W.L.; Yang H.I.; Lee M.H.; Chen H.C.; Chien Y.C.; You S.L.; Epidemiology of virus infection and human cancer. Recherches sur le Cancer 2014,1,11-32","journal-title":"Recherches sur le Cancer"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/cr.2016.153","volume":"27","author":"Tashiro H.","year":"2017","unstructured":"Tashiro H.; Brenner M.K.; Immunotherapy against cancer-related viruses. Cell Res 2017,27(1),59-73","journal-title":"Cell Res"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1002\/ijc.26087","volume":"129","author":"Hoppe-Seyler F.","year":"2011","unstructured":"Hoppe-Seyler F.; Hoppe-Seyler K.; Emerging topics in human tumor virology. Int J Cancer 2011,129(6),1289-1299","journal-title":"Int J Cancer"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1093\/oxfordjournals.bmb.a072910","volume":"50","author":"Vousden K.H.","year":"1994","unstructured":"Vousden K.H.; Farrell P.J.; Viruses and human cancer. Br Med Bull 1994,50(3),560-581","journal-title":"Br Med Bull"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1002\/path.4476","volume":"235","author":"Herrington C.S.","year":"2015","unstructured":"Herrington C.S.; Coates P.J.; Duprex W.P.; Viruses and disease: Emerging concepts for prevention, diagnosis and treatment. J Pathol 2015,235(2),149-152","journal-title":"J Pathol"},{"key":"ref=27","first-page":"495","volume":"56","author":"Delgado-Enciso I.","year":"2004","unstructured":"Delgado-Enciso I.; Rojas-Mart\u00ednez A.; Barrera-Salda\u00f1a H.A.; Ortiz-L\u00f3pez R.; Viruses: An important cause of human cancer. Rev Invest Clin 2004,56(4),495-506","journal-title":"Rev Invest Clin"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1093\/annonc\/6.suppl_1.S69","volume":"6","author":"Rickinson A.B.","year":"1995","unstructured":"Rickinson A.B.; Immune intervention against virus-associated human cancers. Ann Oncol 1995,6(Suppl. 1),69-71","journal-title":"Ann Oncol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.disamonth.2012.01.001","volume":"58","author":"Khayr W.","year":"2012","unstructured":"Khayr W.; Haddad R.Y.; Noor S.A.; Infections in hematological malignancies. Dis Mon 2012,58(4),239-249","journal-title":"Dis Mon"},{"key":"ref=30","first-page":"1574","volume":"3","author":"Kadow J.F.","year":"2002","unstructured":"Kadow J.F.; Regueiro-Ren A.; Weinheimer S.P.; The role of viruses in human cancer development and antiviral approaches for intervention. Curr Opin Investig Drugs 2002,3(11),1574-1579","journal-title":"Curr Opin Investig Drugs"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jhin.2004.09.041","volume":"60","author":"Koltan S.","year":"2005","unstructured":"Koltan S.; Koltan A.; Wysocki M.; Debski R.; Styczynski J.; Anti-HBs profiles in children treated for neoplastic disease who had been vaccinated against hepatitis B postnatally or as infants. J Hosp Infect 2005,60(1),73-77","journal-title":"J Hosp Infect"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/hep.29082","volume":"66","author":"Paul S.","year":"2017","unstructured":"Paul S.; Dickstein A.; Saxena A.; Terrin N.; Viveiros K.; Balk E.M.; Wong J.B.; Role of surface antibody in hepatitis B reactivation in patients with resolved infection and hematologic malignancy: A meta-analysis. Hepatology 2017,66(2),379-388","journal-title":"Hepatology"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1007\/BF00451904","volume":"144","author":"Entacher U.","year":"1985","unstructured":"Entacher U.; J\u00fcrgenssen O.; Thun-Hohenstein L.; Simbruner G.; Khoss A.; Wank H.; Neuwirth G.; Gadner H.; Frisch-Niggemeyer W.; Hepatitis B vaccination and immune response in children with malignant diseases. Eur J Pediatr 1985,144(2),160-163","journal-title":"Eur J Pediatr"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0145-2126(97)00155-0","volume":"22","author":"Goyal S.","year":"1998","unstructured":"Goyal S.; Pai S.K.; Kelkar R.; Advani S.H.; Hepatitis B vaccination in acute lymphoblastic leukemia. Leuk Res 1998,22(2),193-195","journal-title":"Leuk Res"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/bmt.2015.253","volume":"51","author":"Lindemann M.","year":"2016","unstructured":"Lindemann M.; Koldehoff M.; Fiedler M.; Schumann A.; Ottinger H.D.; Heinemann F.M.; Roggendorf M.; Horn P.A.; Beelen D.W.; Control of hepatitis B virus infection in hematopoietic stem cell recipients after receiving grafts from vaccinated donors. Bone Marrow Transplant 2016,51(3),428-431","journal-title":"Bone Marrow Transplant"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.jfma.2015.06.003","volume":"114","author":"Lin C.L.","year":"2015","unstructured":"Lin C.L.; Kao J.H.; Perspectives and control of hepatitis B virus infection in Taiwan. J Formos Med Assoc 2015,114(10),901-909","journal-title":"J Formos Med Assoc"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/B978-0-12-800099-1.00001-6","volume":"84","author":"Ewald P.W.","year":"2014","unstructured":"Ewald P.W.; Swain Ewald H.A.; Joint infectious causation of human cancers. Adv Parasitol 2014,84,1-26","journal-title":"Adv Parasitol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s11060-015-1879-x","volume":"125","author":"Faivre G.","year":"2015","unstructured":"Faivre G.; Thibault V.; Tanguy M.L.; Leblond V.; Choquet S.; Soussain C.; Gonzalez-Aguilar A.; Sierra del Rio M.; Houillier C.; Hoang-Xuan K.; Idbaih A.; Prevalence of hepatitis B virus in primary central nervous system lymphoma. J Neurooncol 2015,125(1),219-221","journal-title":"J Neurooncol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"e303","DOI":"10.3324\/haematol.2016.144840","volume":"101","author":"Kleinstern G.","year":"2016","unstructured":"Kleinstern G.; Seir R.A.; Perlman R.; Abdeen Z.; Khatib A.; Elyan H.; Dann E.J.; Kedmi M.; Ellis M.; Nagler A.; Amir G.; Ben Yehuda D.; Safadi R.; Paltiel O.; Associations between B-cell non-Hodgkin lymphoma and exposure, persistence and immune response to hepatitis B. Haematologica 2016,101(7),e303-e305","journal-title":"Haematologica"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"274","DOI":"10.4140\/TCP.n.2012.274","volume":"27","author":"Johnson T.M.","year":"2012","unstructured":"Johnson T.M.; Treatment and management of chronic lymphocytic leukemia in the elderly: What the pharmacist clinician should know. Consult Pharm 2012,27(4),274-285","journal-title":"Consult Pharm"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1007\/s00432-012-1279-y","volume":"138","author":"Becker N.","year":"2012","unstructured":"Becker N.; Schnitzler P.; Boffetta P.; Brennan P.; Foretova L.; Maynadi\u00e9 M.; Nieters A.; Staines A.; Benavente Y.; Cocco P.; de Sanjose S.; Hepatitis B virus infection and risk of lymphoma: Results of a serological analysis within the European case-control study Epilymph. J Cancer Res Clin Oncol 2012,138(12),1993-2001","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1086\/651231","volume":"201","author":"Fwu C.W.","year":"2010","unstructured":"Fwu C.W.; Chien Y.C.; Nelson K.E.; Kirk G.D.; You S.L.; Kuo H.S.; Feinleib M.; Chen C.J.; Mortality after chronic hepatitis B virus infection: A linkage study involving 2 million parous women from Taiwan. J Infect Dis 2010,201(7),1016-1023","journal-title":"J Infect Dis"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1002\/hep.24150","volume":"53","author":"Fwu C.W.","year":"2011","unstructured":"Fwu C.W.; Chien Y.C.; You S.L.; Nelson K.E.; Kirk G.D.; Kuo H.S.; Feinleib M.; Chen C.J.; Hepatitis B virus infection and risk of intrahepatic cholangiocarcinoma and non-Hodgkin lymphoma: A cohort study of parous women in Taiwan. Hepatology. 2011, 53, 1217-1225.lymphoma: A cohort study of parous women in Taiwan. Hepatology 2011,53(4),1217-1225","journal-title":"Hepatology"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1158\/1055-9965.EPI-10-0889","volume":"20","author":"Franceschi S.","year":"2011","unstructured":"Franceschi S.; Lise M.; Tr\u00e9po C.; Berthillon P.; Chuang S.C.; Nieters A.; Travis R.C.; Vermeulen R.; Overvad K.; Tj\u00f8nneland A.; Olsen A.; Bergmann M.M.; Boeing H.; Kaaks R.; Becker N.; Trichopoulou A.; Lagiou P.; Bamia C.; Palli D.; Sieri S.; Panico S.; Tumino R.; Sacerdote C.; Bueno-de-Mesquita B.; Peeters P.H.; Rodr\u00edguez L.; Barroso L.L.; Dorronsoro M.; S\u00e1nchez M.J.; Navarro C.; Barricarte A.; Regn\u00e9r S.; Borgquist S.; Melin B.; Hallmans G.; Khaw K.T.; Wareham N.; Rinaldi S.; Hainaut P.; Riboli E.; Vineis P.; Infection with hepatitis B and C viruses and risk of lymphoid malignancies in the European Prospective Investigation into Cancer and Nutrition (EPIC). Cancer Epidemiol Biomarkers Prev 2011,20(1),208-214","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1111\/jvh.12713","volume":"24","author":"Huang C.E.","year":"2017","unstructured":"Huang C.E.; Yang Y.H.; Chen Y.Y.; Chang J.J.; Chen K.J.; Lu C.H.; Lee K.D.; Chen P.C.; Chen C.C.; The impact of hepatitis B virus infection and vaccination on the development of non-Hodgkin lymphoma. J Viral Hepat 2017,24(10),885-894","journal-title":"J Viral Hepat"},{"key":"ref=46","first-page":"18","volume":"2","author":"Marcucci F.","year":"2012","unstructured":"Marcucci F.; Spada E.; Mele A.; Caserta C.A.; Pulsoni A.; The association of hepatitis B virus infection with B-cell non-Hodgkin lymphoma - a review. Am J Blood Res 2012,2(1),18-28","journal-title":"Am J Blood Res"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13027-016-0073-x","volume":"11","author":"Taborelli M.","year":"2016","unstructured":"Taborelli M.; Polesel J.; Montella M.; Libra M.; Tedeschi R.; Battiston M.; Spina M.; Di Raimondo F.; Pinto A.; Crispo A.; Grimaldi M.; Franceschi S.; Dal Maso L.; Serraino D.; Hepatitis B and C viruses and risk of non-Hodgkin lymphoma: A case-control study in Italy. Infect Agent Cancer 2016,11,27","journal-title":"Infect Agent Cancer"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s00277-017-3188-2","volume":"97","author":"Wang C.","year":"2018","unstructured":"Wang C.; Xia B.; Ning Q.; Zhao H.; Yang H.; Zhao Z.; Wang X.; Wang Y.; Yu Y.; Zhang Y.; High prevalence of hepatitis B virus infection in patients with aggressive B cell non-Hodgkin\u2019s lymphoma in China. Ann Hematol 2018,97(3),453-457","journal-title":"Ann Hematol"},{"key":"ref=49","unstructured":"Mandatory vaccinations in Europe European Data News HubAvailable from:  (accessed on 28 April 2020).","journal-title":"Mandatory vaccinations in Europe"},{"key":"ref=50","first-page":"24","year":"2017","unstructured":"Global Hepatitis Report World Health Organization (WHO)Available from:  (accessed on 28 April 2020).2017,24-25","journal-title":"Global Hepatitis Report"},{"key":"ref=51","year":"2016","unstructured":"Immunotherapies and vaccines AIRCAvailable from:  (accessed on 10 September 2020).2016","journal-title":"Immunotherapies and vaccines"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"716","DOI":"10.4254\/wjh.v8.i17.716","volume":"8","author":"Zou Z.Q.","year":"2016","unstructured":"Zou Z.Q.; Wang L.; Wang K.; Yu J.G.; Innate immune targets of hepatitis B virus infection. World J Hepatol 2016,8(17),716-725","journal-title":"World J Hepatol"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/B978-0-12-804571-8.00003-2","year":"2018","unstructured":"Tulchinsky, TH creator of vaccines that changed the world. case studies in public health. 2018,443-470"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1586\/erv.10.162","volume":"10","author":"Cooper C.","year":"2011","unstructured":"Cooper C.; Mackie D.; Hepatitis B surface antigen-1018 ISS adjuvant-containing vaccine: A review of HEPLISAV\u2122 safety and efficacy. Expert Rev Vaccines 2011,10(4),417-427","journal-title":"Expert Rev Vaccines"}],"container-title":["Current Pharmaceutical Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1389201023666220113111946","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/200205\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1389201023666220113111946","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,5]],"date-time":"2022-11-05T19:31:44Z","timestamp":1667676704000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/200205\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":54,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389201023666220113111946","relation":{},"ISSN":["1389-2010"],"issn-type":[{"value":"1389-2010","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2021-08-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-04","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}